Blockade of the ALK1 receptor reduces tumour microvessel density and prevents the formation of osteolytic bone disease in the 5T2MM murine model of myeloma.

A. Chantry, Les Coulton, O Gallagher, Holly R. Evans, J. Seehra, S. Pearsall, Hendrik De Raeve, Karin Vanderkerken, Peter I. Croucher

Research output: Contribution to journalConference paper

Abstract

no abstract
Original languageItalian
Pages (from-to)55
Number of pages1
JournalBone
Volume44
Issue number2009
Publication statusPublished - 1 Jun 2009

Keywords

  • ALK1 receptor
  • osteolytic bone disease
  • 5T2MM

Cite this